Last reviewed · How we verify
NCT07374887
Impact of Snoezelen Intervention and Reminiscence Therapy on Seniors' Emotionality and Anxiety
NA trial testing Reminiscence therapy in Emotionality in 55 participants. Completed in 30 September 2023.
1 December 2022
Quick facts
| Lead sponsor | Matej Bel University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | supportive care |
| Enrollment | 55 |
| Start date | 26 October 2022 |
| Primary completion | 1 December 2022 |
| Estimated completion | 30 September 2023 |
| Sites | 1 location across Slovakia |
Drugs / interventions tested
- Reminiscence therapy
- Snoezelen intervention
Conditions studied
- Emotionality — all drugs for Emotionality →
- Anxiety — all drugs for Anxiety →
Sponsor
Matej Bel University
Who can join
62 and older, any sex, with Emotionality or Anxiety. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The aim of the study is to verify and compare the short-term and long-term effectiveness (retention) of Snoezelen intervention and reminiscence therapy and to analyze the dynamics of changes in the level of emotionality and anxiety of seniors in experimental groups and the control group. The main question is: There are significant differences in the level of emotionality (negative and positive emotional states) and anxiety between the two experimental groups of seniors and the control group of seniors during the measurements (pre-test measurement vs. retest measurement I; pre-test measurement vs. retest measurement II; retest measurement vs. retest measurement II)? Researchers will compare seniors receiving Snoezelen intervention, those receiving Reminiscence Therapy, and a control group without intervention to see if the interventions lead to measurable improvements in emotionality and anxiety. Participants will take part in Snoezelen sessions, take part in Reminiscence Therapy sessions, complete pretest, retest and retest II assessments measuring emotionality and anxiety.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT07374887
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Reminiscence therapy
Trials testing the same drug.
- NCT06964399 — The Effect of Reminiscence Therapy in Elderly · NA · recruiting
- NCT06812442 — Effectiveness of a 3-month Individual Reminiscence Therapy Program in Older Adults With Alzheimer's Disease · NA · completed
- NCT06180694 — Reminiscence Therapy in Individuals With Dementia · NA · completed
- NCT05637177 — Preventive Intervention to Promote Healthy Ageing · NA · completed
- NCT04658394 — Effect of Individual Reminiscence Therapy in the Elderly People With Neurocognitive Disorders · NA · completed
Other Matej Bel University trials
Trials by the same sponsor.
- NCT07193706 — Micro-Dosed vs. Traditional Plyometric Training in Elite Youth Soccer · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07374887 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Matej Bel University
- Last refreshed: 29 January 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07374887.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing